Myelodysplasic syndromes (MDS) are diseases occurring mainly in the elderly population.
Although hematopoietic stem cell transplantation is the only hope for cure, a majority of the …

Simple Summary Secondary acute myeloid leukemia (s-AML) refers to the development of
AML following myelodysplatic syndrome or other hematological malignancies, or after a …

The myelodysplastic syndromes (MDS) represent a heterogeneous group of clonal
hematopoietic disorders characterized by cytopenias, dysplasia in one or more myeloid …

The myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell
disorders characterized by cytopenias, dysplastic changes in the hematopoietic precursors …

Hemopoietic cell transplantation (HCT) is presently the only therapy with curative potential
for myelodysplastic syndromes (MDS) and myeloproliferative disorders (MPD). Among …

Hematopoietic cell transplantation (HCT) is currently the only treatment with curative
potential for myelodysplastic syndromes (MDS) and myeloproliferative disorders (MPD) …

Introduction Posaconazole is superior to fluconazole (FLU) and itraconazole (ITRA) in the
prevention of invasive fungal diseases (IFDs) in neutropenic patients with acute …

The purpose of this study was to evaluate the feasibility and efficacy of allogeneic
hematopoietic stem cell transplantation with a reduced-intensity regimen (RIST) in patients …

Background: Thalidomide inhibits angiogenesis and exerts complex immunomodulatory
activities. This phase II study aimed to examine the efficacy of thalidomide in Taiwanese …

Allogeneic blood and marrow transplantation (alloBMT) remains the only curative treatment
for patients with myelodysplastic syndromes (MDS), but its application has been limited by …